Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-03

Clinical Trial Update: Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 update suggests that olanzapine may improve chemotherapy tolerance in advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

Sponsor: Peking University | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN